Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

PCOS is a common condition in women that can lead to infertility and other health issues, and it's diagnosed by specific criteria with various treatment options available.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

A toddler with a rare adrenal gland tumor causing male-like physical changes was successfully treated with surgery.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.